BIOA (Bioage Labs) Total Equity : $323.13 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs Total Equity?

Bioage Labs's total equity for the quarter that ended in Dec. 2024 was $323.13 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bioage Labs Total Equity Historical Data

The historical data trend for Bioage Labs's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs Total Equity Chart

Bioage Labs Annual Data

Trend

Dec22

Dec23

Dec24

Total Equity

-112.56

-173.40

323.13

Bioage Labs Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Equity	Get a 7-Day Free Trial				-173.40	-185.51	-197.13	313.75	323.13

Bioage Labs Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bioage Labs's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	358.234	-	35.107
	=	323.13

Bioage Labs's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	358.234	-	35.107
	=	323.13

Bioage Labs Total Equity Related Terms

Thank you for viewing the detailed overview of Bioage Labs's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioage Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1445A South 50th Street, Richmond, CA, USA, 94804

Website

https://www.bioagelabs.com

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.